SynthesisThe Journal of bone and joint surgery. American volume2026
No Mid-Term Benefits of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Following Total Joint Arthroplasty: A Systematic Review.
Filippo Leggieri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.